News
Teleflex lands FDA win for Arrow UltraQuik needles
Fri, 01/25/2013 - 1:29pm
Medical device company Teleflex touts 510(k) clearance for its Arrow UltraQuik peripheral nerve block needles.
Limerick, Pa.-based Teleflex (NYSE:TFX) won FDA clearance for the latest in its line of peripheral nerve block needles, the Arrow UltraQuik.
The Arrow UltraQuik joins Teleflex's StimuQuik and StimuQuik Echo, devices aimed at helping physicians perform nerve blocking, whether with ultrasound alone, via nerve stimulation, or through a combined approach, according to a press release.
